What’s all the buzz? BioViva Platform for Expedited Drug Development
BioViva was created to accelerate the development of drugs that can improve human health. BioViva developed a set of biomarkers for aging that includes molecular markers, physiological markers, anatomical markers, clinical and qualitative ones. BioViva collaborates with biomedical researchers, clinicians and statisticians in order to create innovative protocols for adaptive trials of gene and cell therapies. BioViva also built a bioinformatics system to analyze data from human trials that measure biomarkers for aging and validate treatments effective in treating the aging processes.
BioViva recently partnered up with Integrated Health Systems, a company that offers paid clinical trials. IHS is a company that connects doctors and patients interested in participating in clinical trials. In our collaboration with IHS, they will use our adaptive clinical trials protocols to conduct gene therapy and cell therapies. BioViva’s comprehensive platform for biomarkers will be used to test all patients before and after treatment. Our bioinformatics pipeline will assess treatment efficacy and patient wellbeing.
BioViva’s goal is to develop products that are cost-effective and effective in treating biological aging. Our platform provides rapid and reliable feedback for our manufacturing and clinical partners so they can quickly iterate on their products and services in order to improve the quality of and quantity life for patients.